Preliminary Toxicological Analysis in a Safe-by-Design and Adverse Outcome Pathway-Driven Approach on Different Silver Nanoparticles: Assessment of Acute Responses in A549 Cells
暂无分享,去创建一个
[1] Yiru Niu,et al. In vitro review of nanoparticles attacking macrophages: Interaction and cell death. , 2022, Life sciences.
[2] S. Parapini,et al. Eco design for Ag-based solutions against SARS-CoV-2 and E. coli , 2022, Environmental Science: Nano.
[3] M. Eskandani,et al. Recent advances in γH2AX biomarker-based genotoxicity assays: A marker of DNA damage and repair. , 2021, DNA repair.
[4] Arandi Ginane Bezerra Junior,et al. Toxicological effects of silver nanoparticles and cadmium chloride in macrophage cell line (RAW 264.7): An in vitro approach. , 2021, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[5] F. Cassee,et al. Safe by design (SbD) and nanotechnology: a much-discussed topic with a prudence? , 2021, Particle and fibre toxicology.
[6] M. Garcés,et al. Current understanding of nanoparticle toxicity mechanisms and interactions with biological systems , 2021, New Journal of Chemistry.
[7] Nelson Caro,et al. Silver Nanoparticles and Their Antibacterial Applications , 2021, International journal of molecular sciences.
[8] M. Peana,et al. An updated overview on metal nanoparticles toxicity. , 2021, Seminars in cancer biology.
[9] S. Nabavi,et al. Reactive oxygen species modulators in pulmonary medicine. , 2021, Current opinion in pharmacology.
[10] T. Douki,et al. Toxicity and chemical transformation of silver nanoparticles in A549 lung cells: dose-rate-dependent genotoxic impact , 2021, Environmental Science: Nano.
[11] E. Demir. A review on nanotoxicity and nanogenotoxicity of different shapes of nanomaterials , 2020, Journal of applied toxicology : JAT.
[12] J. Boratýnski,et al. Hydroxyethylcellulose as a methotrexate carrier in anticancer therapy , 2020, Investigational New Drugs.
[13] U. Vogel,et al. Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale , 2020, Particle and Fibre Toxicology.
[14] L. Delgado-Roche,et al. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection , 2020, Archives of Medical Research.
[15] Manfred Zinn,et al. A Methodological Safe-by-Design Approach for the Development of Nanomedicines , 2020, Frontiers in Bioengineering and Biotechnology.
[16] Joel N. Meyer,et al. Caveats to the use of MTT, neutral red, Hoechst and Resazurin to measure silver nanoparticle cytotoxicity. , 2020, Chemico-biological interactions.
[17] N. Durán,et al. Silver nanoparticles: Toxicity in model organisms as an overview of its hazard for human health and the environment. , 2019, Journal of hazardous materials.
[18] M. Selman,et al. The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis. , 2019, Cellular signalling.
[19] M. Bottone,et al. Pulmonary and hepatic effects after low dose exposure to nanosilver: Early and long-lasting histological and ultrastructural alterations in rat , 2019, Toxicology reports.
[20] M. Blosi,et al. Innovative synthesis of nanostructured composite materials by a spray-freeze drying process: Efficient catalysts and photocatalysts preparation , 2019, Catalysis Today.
[21] A. Pugazhendhi,et al. Synthesis of Silver Nanoparticles and their Biomedical Applications - A Comprehensive Review. , 2019, Current pharmaceutical design.
[22] A. Khademhosseini,et al. Recent advances in nanoengineering cellulose for cargo delivery. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[23] E. Rahimpour,et al. Effect of silver nanoparticles in the induction of apoptosis on human hepatocellular carcinoma (HepG2) cell line. , 2018, Materials science & engineering. C, Materials for biological applications.
[24] S. Gurunathan,et al. Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer , 2018, International journal of molecular sciences.
[25] H. Griffiths,et al. The dual role of Reactive Oxygen Species in autoimmune and inflammatory diseases: evidence from preclinical models , 2018, Free radical biology & medicine.
[26] Alexandru Mihai Grumezescu,et al. Biomedical Applications of Silver Nanoparticles: An Up-to-Date Overview , 2018, Nanomaterials.
[27] D. Gardini,et al. Nanosilver: An innovative paradigm to promote its safe and active use , 2018, NanoImpact.
[28] Stephen W. Edwards,et al. The Adverse Outcome Pathway: A Multifaceted Framework Supporting 21st Century Toxicology. , 2018, Current opinion in toxicology.
[29] Adriele Prina-Mello,et al. Silver nanoparticles as a medical device in healthcare settings: a five-step approach for candidate screening of coating agents , 2018, Royal Society Open Science.
[30] Valeria De Matteis,et al. Toxicity Assessment in the Nanoparticle Era. , 2018, Advances in experimental medicine and biology.
[31] S. H. Bennekou,et al. Adverse outcome pathways: opportunities, limitations and open questions , 2017, Archives of Toxicology.
[32] A. T. Ogunjimi,et al. Evaluation of distribution, redox parameters, and genotoxicity in Wistar rats co-exposed to silver and titanium dioxide nanoparticles , 2017, Journal of toxicology and environmental health. Part A.
[33] Hayelom Dargo Beyene,et al. Synthesis paradigm and applications of silver nanoparticles (AgNPs), a review , 2017, Sustainable Materials and Technologies.
[34] V. Castranova,et al. Role of epithelial‐mesenchymal transition (EMT) and fibroblast function in cerium oxide nanoparticles‐induced lung fibrosis , 2017, Toxicology and applied pharmacology.
[35] Sharon Munn,et al. The Adverse Outcome Pathway approach in nanotoxicology , 2017 .
[36] Lei Dong,et al. Specifically Formed Corona on Silica Nanoparticles Enhances Transforming Growth Factor β1 Activity in Triggering Lung Fibrosis. , 2017, ACS nano.
[37] Anne Gourmelon,et al. The Adverse Outcome Pathway Concept: A Basis for Developing Regulatory Decision-making Tools , 2016, Alternatives to laboratory animals : ATLA.
[38] Xiaoxu Zhao,et al. Coexposure to silver nanoparticles and ultraviolet A synergistically enhances the phosphorylation of histone H2AX. , 2016, Journal of photochemistry and photobiology. B, Biology.
[39] Y. Hashimoto,et al. A Review of Silver Nanoparticles: Synthesis Methods, Properties and Applications , 2015 .
[40] J. Ravanat,et al. Stress-induced DNA damage biomarkers: applications and limitations , 2015, Front. Chem..
[41] Meiying Wang,et al. NADPH Oxidase-Dependent NLRP3 Inflammasome Activation and its Important Role in Lung Fibrosis by Multiwalled Carbon Nanotubes. , 2015, Small.
[42] S. Gurunathan,et al. Oxidative stress mediated cytotoxicity of biologically synthesized silver nanoparticles in human lung epithelial adenocarcinoma cell line , 2014, Nanoscale Research Letters.
[43] V. Kähäri,et al. Matrix metalloproteinases in inflammation. , 2014, Biochimica et biophysica acta.
[44] M. Camatini,et al. Nickel oxide nanoparticles induce inflammation and genotoxic effect in lung epithelial cells. , 2014, Toxicology letters.
[45] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[46] M. Camatini,et al. The modality of cell-particle interactions drives the toxicity of nanosized CuO and TiO₂ in human alveolar epithelial cells. , 2013, Toxicology letters.
[47] H. Simon,et al. Living and dying for inflammation: neutrophils, eosinophils, basophils. , 2013, Trends in immunology.
[48] M. Teixeira,et al. Resolution of inflammation: mechanisms and opportunity for drug development. , 2013, Pharmacology & therapeutics.
[49] Bernd Nowack,et al. 120 years of nanosilver history: implications for policy makers. , 2011, Environmental science & technology.
[50] Holger Moch,et al. Nanoparticle cytotoxicity depends on intracellular solubility: comparison of stabilized copper metal and degradable copper oxide nanoparticles. , 2010, Toxicology letters.
[51] V. Vishwakarma,et al. Safety and Risk Associated with Nanoparticles - A Review , 2010 .
[52] K. Hensley,et al. Inhalation of environmental stressors & chronic inflammation: autoimmunity and neurodegeneration. , 2009, Mutation research.
[53] P. Beard,et al. H2AX Is Required for Cell Cycle Arrest via the p53/p21 Pathway , 2009, Molecular and Cellular Biology.
[54] Naomi Lubick,et al. Nanosilver toxicity: ions, nanoparticles--or both? , 2008, Environmental science & technology.
[55] Z. Darżynkiewicz,et al. ATM activation accompanies histone H2AX phosphorylation in A549 cells upon exposure to tobacco smoke , 2007, BMC Cell Biology.
[56] V. Castranova. Signaling pathways controlling the production of inflammatory mediators in response to crystalline silica exposure: role of reactive oxygen/nitrogen species. , 2004, Free radical biology & medicine.
[57] Tzu-Hao Wang,et al. Detection and treatment of mycoplasma contamination in cultured cells. , 2003, Chang Gung medical journal.